Cardiff Oncology (NASDAQ:CRDF) , a clinical-stage biotech company specializing in new cancer treatments, saw its share price rise as high as $7.18 on Monday. It closed the day at $6.74, up about 7% from its previous close.
Itron, Inc. (NASDAQ:ITRI) has earned a consensus recommendation of "Buy" from the ten brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, six have assigned a buy recommendatio
A single Bitcoin (CRYPTO: BTC) transaction worth over $2 billion was processed for under $1.
What Happened: According to data from Blockchain.com, more than 44,500 BTC worth $2,011,009,391 moved from one anonymous crypto wallet to another for as little as 78 cents in transaction fees.
An international transfer of the same size would typically involve a transfer fee of between 1% and 3%. Even a transfer fee of 1% on a $2-billion transfer would cost at least $20 million and take between one and four days to process.
Despite surging to a record high of $62 earlier this....More>>>
For David Gardner, the Rule Breaker Investing podcast isn’t so much a monologue as it is an extended chat with you, his listeners and readers, which is one reason he ends every month with a mailbag episode — so that he can bring your viewpoints and questions directly into the conversation.
In this segment, he shares an email — and a scorecard — from a listener who took a bit of a leap of faith. At the beginning of 2017, he opened positions in the five biggest losers in the Rule Breaker universe for 2016: Restoration Hardware (NYSE:RH), Juno Therapeutics, FireEye....More>>>
With the rapid spread of the highly contagious Delta variant of the coronavirus, Hawaiian Holdings (HA Quick QuoteHA ) recently trimmed its outlook for the third quarter of 2021. This bearish view adds to the carrier’s woes, shares of which have declined 29.1% over the past three
Assurant, Inc. (AIZ Quick QuoteAIZ ) has been favored by investors on the back of continued organic growth across distribution channels, inorganic and organic growth strategies and effective capital deployment.
HealthEquity, Inc. (NASDAQ:HQY) – Equities researchers at KeyCorp increased their Q3 2022 earnings per share (EPS) estimates for shares of HealthEquity in a research note issued to investors on Wednesday, September 8th. KeyCorp analyst D. Hooker now anticipates that the company